The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate‐risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low‐dose rate (LDR) brachytherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1464-410x|114|6|865-871

ISSN： 1464-4096

Source： BJU INTERNATIONAL, Vol.114, Iss.6, 2014-12, pp. : 865-871

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Conformal radiotherapy plus high dose rate brachytherapy prostate boost in patients with intermediate and high risk prostate cancer: our experience in Asian males

By  

Journal of Radiotherapy in Practice, Vol. 11, Iss. 4, 2012-05 ,pp. : 257-270

Cambridge University Press

Access to resources Recommend Favorite

Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate‐risk prostate cancer treated using radical prostatectomy

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 11, 2015-11 ,pp. : 1029-1035

John Wiley & Sons Inc

Access to resources Recommend Favorite

Determinants of the combined use of external beam radiotherapy and brachytherapy for low‐risk, clinically localized prostate cancer

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3619-3628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial Comment to Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate‐risk prostate cancer treated using radical prostatectomy

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 11, 2015-11 ,pp. : 1035-1036

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stratification of patients with intermediate‐risk prostate cancer

By  

BJU INTERNATIONAL, Vol. 115, Iss. 6, 2015-06 ,pp. : 907-912

John Wiley & Sons Inc

Access to resources Recommend Favorite